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Abstract
There are limited data on the incidence and management of acute faecal incontinence with diarrhoea in the ICU. The
FIRSTTM Observational Study was undertaken to obtain data on clinical practices used in the ICU for the management of
acute faecal incontinence with diarrhoea in Germany, UK, Spain and Italy. ICU-hospitalised patients 518 years of age
experiencing a second episode of acute faecal incontinence with diarrhoea in 24 h were recruited, and management
practices of acute faecal incontinence with diarrhoea were recorded for up to 15 days. A total of 372 patients had
complete data sets; the mean duration of study was 6.8 days. At baseline, 40% of patients experienced mild or moderate-
to-severe skin excoriation, which increased to 63% in patients with acute faecal incontinence with diarrhoea lasting >15
days. At baseline, 27% of patients presented with a pressure ulcer, which increased to 37%, 45% and 49% at days 5, 10 and
15, respectively. Traditional methods (pads, sheets and tubes) were more commonly used compared to faecal manage-
ment systems during days 1–4 (76% vs. 47% faecal management system), while the use of a faecal management system
increased to 56% at days 5–9 and 61% at days 10–15. At baseline, only 26% of nurses were satisfied with traditional
management methods compared to 69% with faecal management systems. For patients still experiencing acute faecal
incontinence with diarrhoea after 15 days, 82% of nurses using a faecal management systems to manage acute faecal
incontinence with diarrhoea were satisfied or very satisfied, compared to 37% using traditional methods. These results
highlight that acute faecal incontinence with diarrhoea remains an important healthcare challenge in ICUs in Europe; skin
breakdown and pressure ulcers remain common complications in patients with acute faecal incontinence with diarrhoea
in the ICU.
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Introduction
Faecal incontinence presents a major challenge for
healthcare professionals, and has been reported to
aﬀect a substantial number of patients in acute
care.1 The condition is associated with a number of
clinical issues, including the risk of perineal dermatitis
and cross-contamination with pathogens responsible
for healthcare-associated infections (HCAIs).1–3 The
management of faecal incontinence in the acute care
setting also requires considerable nursing time and
treating the associated complications can result in
increased hospital stays and hospital costs.4–7
Although there is an increasing body of evidence
regarding the prevalence and consequences of chronic
faecal incontinence in community and nursing homes,
there is currently a lack of information regarding the
prevalence and management of acute faecal incontin-
ence with diarrhoea (AFId) in acutely or critically ill
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hospitalised patients, with only a small number of
reports describing the speciﬁc problem of AFId in
the ICU and its incidence.8–19 Similarly, there is
little available data on the incidence of the clinical
consequences of AFId in this setting.9–21
To better understand speciﬁc issues related to
AFId in European ICUs, the FIRSTTM (Faecal
Incontinence Re-evaluation STudy) programme was
initiated by a group of healthcare professionals
involved in the management of critical care patients,
supported by an educational grant from ConvaTec.
The FIRSTTM programme aims to gather data on
AFId and raise awareness of the prevalence, asso-
ciated clinical consequences and current management
of the condition.22 As part of the initiative, a deﬁn-
ition of AFId was agreed upon to distinguish it from
other descriptions of faecal incontinence that are not
relevant for the ICU. ‘‘AFId’’ is thus deﬁned as at
least two episodes of faecal incontinence with diar-
rhoea – liquid or semi-liquid stool (according to the
Bristol Stool chart23) – in a 24-h time period. It should
be noted that AFId does not refer to continent
patients with diarrhoea who are still able to use
toilet facilities.24
This initiative included the FIRSTTM Survey,
which aimed to provide a snapshot of AFId in
Europe across ICUs in four European countries
(Germany, Italy, Spain and UK).9,22 Importantly,
the FIRSTTM Survey identiﬁed low awareness of the
clinical challenges associated with AFId and substan-
tial variability in management strategies, possibly
reﬂecting the absence of management recommenda-
tions for AFId in the countries surveyed. To address
this, a set of expert recommendations was developed
to aid carers in understanding AFId and its clinical
consequences and to provide guidance on the most
appropriate management options, depending on indi-
vidual patient risk factors and comorbidities.24
Following the results of the FIRSTTM Survey,
which were published in 2012, a second phase of the
FIRSTTM programme was initiated – a prospective,
observational, multicentre study to obtain data on
current routine clinical practices in the management
of AFId in the critical care setting in selected
European countries through the use of site staﬀ assess-
ments. Here we present the results of the FIRSTTM
Observational Study, which provide insights into the
real-world clinical challenges associated with AFId and
its management in the ICU, which may also provide
additional information and support for the use of
expert consensus recommendations for the manage-
ment of AFId in daily clinical practice.
Methodology
Study design
The primary objective of this non-interventional,
observational study was to obtain data on current
routine clinical practices in the management of
AFId in Germany, Spain, Italy and the UK.
Secondary objectives were to document the incidence
and prevalence of AFId, to understand the conse-
quences of AFId on the integrity of the perineal
skin and the development of pressure ulcers (PUs),
to document staﬀ satisfaction with current manage-
ment methods and to understand the total time spent
managing AFId.
Patients and data collection
In August 2011, the initial recruitment of patients
began in 46 sites across the four countries. Inclusion
criteria were: male and female ICU hospitalised
patients 518 years of age experiencing a second
episode of AFId in 24 h. Other than the minimum
age limit, there were no exclusion criteria as the
study aim was to observe and record AFId manage-
ment in real-life conditions. The primary and second-
ary objectives were monitored over an observational
time period of 15 days, but patients left the study
earlier if symptoms related to AFId resolved or they
were discharged from the ICU. By the time the ﬁnal
patient was recruited in July 2012, 435 patients had
been enrolled. Patient data were obtained prospect-
ively by clinicians via an electronic data capture
system using an electronic case report form (eCRF)
provided for this study. A daily diary was also com-
pleted by nursing staﬀ to record the number of
patients with AFId, the number of new patients
with AFId, the number of patients present in the
ICU and the number of patients who left the ICU
in order to determine incidence and prevalence.
Only complete sets of data for each patient were
used for the analysis. Written informed consent was
obtained from all patients before enrolment. The
institutional review board at each participating
centre approved the study, which was conducted in
accordance with the principles of Good Clinical
Practice, the provisions of the Declaration of
Helsinki, and other applicable local regulations.
AFId management methods
For the purpose of the analysis, patients were
described as being treated with either traditional man-
agement methods, comprising pads, sheets, faecal col-
lectors and tubes, or with a faecal management system
(FMS). This was an observational study, which did
not evaluate the outcome of an intervention and only
recorded outcomes when they occurred.
Data analyses
Descriptive analyses were performed for both the pri-
mary and secondary objectives. Categorical variables
were reported using frequency tables. Continuous
variables were summarised using means, standard
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deviations, and minimum and maximum values. In
the event that a continuous variable was assessed
over time, changes in the variable were reported
using change from baseline values (visit valuebase-
line value). No statistical inferences were derived for
this descriptive study.
The FIRSTTM Observational Study advisory board
The study concept and design of the FIRSTTM
Observational Study was guided and supported by
an international board of experts from across
Europe. Each member is directly involved in the man-
agement and care of critically ill patients.
Results
Patient characteristics and disposition
Of the 435 patients who were enrolled, complete data
sets were available for 372 patients and included in the
analysis; any unresolved data entries for any patient
were classiﬁed as ‘‘incomplete’’. Table 1 shows the
distribution of patients per centre and per country.
The mean age was 60.6 years, and 60% of patients
were male. The mean weight of patients was 77.2 kg
and mean BMI was 26.9.
The mean time of the patient in the study was 6.8
days; only 12.9% of patients remained for the full 15-
day study period (Table 2). The main reason for early
exit from the study was cessation of AFId (58.6%)
and discharge from the ICU (28.1%). Surgical and
medical patients were included (Table 3). The propor-
tion of patients with enteral feeding (580%) and
mechanical ventilation (>75%) remained high
throughout the 15-day study period, while the per-
centage of patients on antibiotics tended to decrease,
from 88% on day 1, 83% on day 5, 75% on day 10 to
73% on day 15.
The baseline sequential organ failure assessment
(SOFA) score (index of disease severity) was 7.2 for
patients using an FMS at baseline and 6.7 for those
using traditional methods. There was little variation
in the SOFA score throughout the study (6.8 on days
1 and 5, 7.1 on day 10 and 7.5 on day 15). Baseline
Braden scores (risk of PU) were 11.0 and 11.3 for
those using FMS or traditional methods, respectively
(Figure 1).
Incidence and prevalence of AFId
The incidence of AFId, calculated as the ratio of the
number of patients with at least one incidence of
faecal incontinence over the total time at risk among
all patients, was 795 per 10,000 patient-days
(Figure 2). The prevalence of AFId, the ratio of the
number of patients with AFI over the number of
patients in the ICU, was 17.4% (Figure 3). Some
Table 2. Duration of study and reasons for early cessation.
% Patients
(n¼ 372)
Patients completing all
15 study days
12.9
Primary reason for
discontinuation
Death 10.2
Cessation of AFId 58.6
Discharge from ICU 28.1
Other (hospital discharge,
consent withdrawal, etc.)
3.1
Mean duration of AFId 6.8 days
7.2
11.0
6.7
11.3
Severity (SOFA Score) Risk of Pressure Ulcer (Braden
Score)
FMS
Tradional Method
Figure 1. Baseline characteristics for patients managed with
traditional methods or FMS.
FMS: faecal management system; SOFA: sequential organ failure
assessment.
Table 3. Reasons for ICU hospitalisation.
% Patients
Pulmonary 27.4
Cardiovascular 14.0
Infection 12.9
Neurological 11.0
Gastrointestinal 9.4
Trauma 8.3
Other (metabolic, renal, malignancy, etc.) 17.0
Table 1. Patient distribution.
Country
Centres
(n)
Patients
enrolled (n)
Patients
analysed (n)
Germany 10 88 85
Spain 13 127 91
Italy 13 142 125
UK 10 78 71
Total 46 435 372
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variations were observed in the incidence and preva-
lence between countries.
Skin integrity
At baseline, approximately 40% of patients overall
experienced either mild or moderate-to-severe skin
excoriation. This proportion increased in patients
with AFId of longer duration (5–10 days); in patients
with AFId lasting 15 days, mild skin excoriation was
observed in approximately 37% of patients and mod-
erate-to-severe excoriation in 25.5% (Figure 4). At
baseline, 27% of patients presented with at least one
PU in the sacral, perineal/buttocks area. This
increased to 37%, 45% and 49% at days 5, 10 and
15, respectively. The risk of developing a PU was high
for all patients throughout the study (range 11.0–
12.4). No notable diﬀerences were seen in increased
skin excoriation or increased risk of developing a PU
between patients receiving traditional management vs.
FMS over the course of the observational period.
Management methods and nurse satisfaction
Various management methods were used over the
course of the study: diapers and pads, incontinence
sheets, faecal collectors, faeces-diverting tubes (all
classed as traditional management methods) and
FMSs. Overall, traditional methods, i.e. pads, sheets
and tubes, were most commonly used to manage
AFId during the initial days (days 1–4) of the study
(76% traditional vs. 47% FMS). The use of FMS
increased over the course of the observational
period to 56% at days 5–9 and 61% at days 10–15
(Figure 5). The exact usage of FMS to manage AFId
varied from country to country; however, Spain was
found to implement FMS as the sole management
method in only 4% of cases at baseline, whereas the
UK implemented FMS with a much higher frequency,
in around 20% of cases (data not shown).
In the cases where FMS was implemented, nurses
were more satisﬁed managing AFId than with trad-
itional methods (Figure 6). At baseline, only 26% of
nurses were satisﬁed with traditional management
methods compared to 69% with FMS. For patients
who were still experiencing AFId after 15 days, 82%
of nurses using FMS to manage AFId were satisﬁed
or very satisﬁed compared to 37% of nurses using
traditional methods.
Discussion
The results of the FIRSTTM Observational Study
highlight that AFId remains an important healthcare
challenge in ICUs in Europe. In this observational
study, the overall prevalence of AFId was 17.4%
which is in broad agreement with the estimated preva-
lence of 9–37% reported in the FIRSTTM Survey.22
Variation in the prevalence of AFId was observed
between countries, as was also seen in the FIRSTTM
Survey.22 Wide variation in the reported prevalence of
AFId in the acute care setting has been noted in pre-
vious investigations, ranging from 6.6 to 33% in two
studies in the US,5,22 6.4% in a Spanish study10 and
22.4% in a UK-based study.9 While deﬁnitions in the
two FIRSTTM studies were standardised, the patient
case-mix present in the ICU at any given moment and
diﬀerences in the use of antibiotics or parenteral feed-
ing can contribute to variations in the prevalence of
AFId, in addition to other unquantiﬁable variances.
One of the primary goals in the management of
AFId is maintenance of skin integrity. Importantly,
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Figure 3. Prevalence of AFId overall and for each country.
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Figure 2. Incidence of AFId overall and for each country.
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at baseline, around 40% of patients already experi-
enced either mild or moderate-to-severe skin excori-
ation. This percentage further increased in patients
with long-lasting AFId. Moderate-to-severe excori-
ation and PUs in the sacral, perineal/buttocks areas
were also prevalent. FMSs are speciﬁcally designed to
protect the skin from contact with faecal waste that
can cause skin breakdown, moisture wounds, and lead
to the development of PUs.25 The majority of the
patients in the study did not have an FMS until 5–9
days after the onset of AFId, and even after long-
lasting AFId (>10 days) 39% still did not have an
FMS in situ. In this observational study, no notable
diﬀerences were seen in skin outcomes between man-
agement methods. However, the proportion of
patients with an FMS increased over the course of
the study compared with traditional methods. This
might suggest that caregivers believe that an FMS is
important in avoiding incontinence-associated com-
plications and reducing the time spent managing epi-
sodes of diarrhoea in patients requiring longer stays in
the ICU or may reﬂect the use of FMS for patients
who are more critically ill. FMS use was slightly
higher in patients with higher SOFA score at the
start of the study. However, this observational study
was not designed to investigate the reasons why a
particular management method was chosen, or to
investigate clinical outcomes associated with a par-
ticular management approach. Similarly, to avoid
bias, it was not possible to collect data on reasons
for changes in management during the observational
period.
Use of FMS was associated with substantially
higher satisfaction in managing AFId among nurses
compared with traditional methods, particularly for
long-lasting AFId. At baseline, only 26% of nurses
reported satisfaction with traditional methods com-
pared to 69% with an FMS. At the end of the
study, the percentage of nurses reporting satisfaction
with an FMS increased to 82%, while only 37% were
satisﬁed with traditional care. Greater satisfaction
with FMS may be related to the possibility that it
has the potential to reduce the time spent managing
AFId episodes and better control of unpleasant odour
compared to traditional pads and sheets. In patients
who are managed using an FMS, once the device is in
place it is diﬃcult to ascertain nursing time required
for managing incontinence episodes. In this observa-
tional study, approximately 0.7 nursing hours per day
were required to manage AFId episodes using trad-
itional management methods. In the FIRSTTM
Survey it was found that approximately 10–20min
are spent managing an AFId episode, and most
nurses estimated that three nursing staﬀ were
required.22 Thus, one patient experiencing ﬁve epi-
sodes of AFId in a 24-h period managed by three
nursing staﬀ for 15min each episode would consume
3.75 h of nursing time.22 This highlights that, although
the cost of pads may be low and the time for staﬀ
training short, the overall costs of managing frequent
and persistent AFId episodes can be signiﬁcant.
Overall costs must take into consideration the time
spent by care providers to manage each episode, the
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Figure 5. Management method.
FMS: faecal management system.
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Figure 6. Nurse satisfaction with AFId management methods.
FMS: faecal management system.
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large number of replacement pads used, and the add-
itional costs of managing the spread of infections
through inadequately contained, infected faeces. In a
previous study, it has already been noted that there is
signiﬁcant utilisation of healthcare resources, includ-
ing nursing time, associated with the management of
AFId that may not be widely recognised.6
The FIRSTTM Survey reported a ‘‘low to moder-
ate’’ appreciation of the problems associated with
AFId among both nurses and physicians, and that
despite a range of management methods available,
around 50% of the respondents reported a lack of
standard protocols or guidelines in their respective
ICUs.22 Although not available at the time of this
observational study, standard management plans or
protocols could have a positive impact on reducing
the clinical complications associated with AFId
whilst ensuring the best use of time and resources.
In this regard, a set of expert recommendations were
published whilst this study was ongoing to aid carers
managing AFId and its clinical consequences, and to
help them to administer the most appropriate man-
agement options, depending on individual patient risk
factors and comordibities.24 The treatment algorithm
recommends that after diagnosis of AFId (a second
episode of faecal incontinence with diarrhoea (liquid
or semi-liquid stool, Bristol stool chart type 6–7) in
24 h), patients are categorised as:
1. those with good prognosis, and
2. those with, or at risk of developing, complications.
As the former group are well nourished/hydrated
and are predicted to have a short hospital stay, they
can be managed using traditional methods. The group
having AFId with, or at risk of, developing complica-
tions includes those with a risk of skin breakdown in
the perineal region; at risk of cross infection; reduced
mobility; long-lasting diarrhoea; other clinical condi-
tions. In such patients, an FMS is recommended
whenever possible.
This study does have a number of limitations, par-
ticularly the limitations inherent in the design of an
observational study, which may be subject to bias.
The study was carefully designed to minimise poten-
tial bias, although clearly this reduces the possibility
to correlate the observations with factors inﬂuencing
management choices or impact on clinical outcomes.
Another limitation of this study is the selection of
hospitals and ICUs across the diﬀerent countries,
which may vary signiﬁcantly. The aim was to ensure
a cross-sectional selection of hospitals for example
according to size and teaching status, but since only
approximately 10 centres from each country were
included it is challenging to be fully representative
of hospital-based clinical practice in these countries,
and this may also have an inﬂuence on the use or
availability of diﬀerent management methods for
AFId. However, even with these limitations, this
observational study does provide additional insights
into current clinical practice regarding the manage-
ment of AFId. Since the completion of this study,
and with the availability of expert recommendations,
it may now be timely to review how this increasing
understanding of the impact and consequences of
AFId in the ICU may have inﬂuenced management
practices over the short term, and ideally help identify
how this complex clinical condition could be better
managed in the future.
Conclusions
The FIRSTTM Observational Study provides add-
itional conﬁrmation that there are still clinical chal-
lenges and substantial variability in the management
of AFId in Europe and that AFId remains an import-
ant healthcare challenge in ICUs in Europe; skin
breakdown and PUs remain common complications
in patients with AFId in the ICU. Variations in the
observed results between countries also suggest that
there are diﬀerences between European countries in
how AFId is managed in ICUs. It is hoped that this
additional observation data on current management
of AFId, together with published expert recommenda-
tions,24 may help to further raise awareness of this
important component of ICU management
and improve the current management of AFId in
the ICU.
Centres participating in the FIRSTTM
Observational Study
Germany
Universita¨tsmedizin Rostock
Hausanschrift, Schillingallee 35, Postfach 100888.
18057 Rostock
BG Berufsgenossenschaftliche Unfallklinik Tuebingen
BG Klinik Tu¨bingen, Schnarrenbergstrasse 95, 72076
Tu¨bingen
Sta¨dt. Klinikum Bogenhausen Mu¨nchen
Englschalkinger Strasse 77, 81925 Mu¨nchen
Universita¨tsklinikum Bonn
Sigmund-Freud-Str. 25 53127 Bonn
Marien-Hospital Aachen
Zeise 4 52066 Aachen
Universita¨tsklinikum Regensburg
Franz-Josef-Strauss-Allee 11, 93053 Regensburg
Universtita¨sklinikum Magdeburg
Leipziger Str. 44, 39120 Magdeburg
Klinik Aschersleben-Stassfurt
Eislebener Str. 7a, 06449 Aschersleben
Universita¨tsklinikum Charite´ Berlin
Charite´ Campus Virchow-Klinikum, Augustenburger
Platz 1, 13353 Berlin
Vivantes Neuko¨lln, Berlin
Vivantes Netzwerk f. Gesundheit GmbH, Klinikum
Neuko¨lln, Rudowerstr. 48, 12351 Berlin
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Italy
Azienda Ospedaliera Universitaria Pisana
Via Paradisa 2, 56126 Pisa
Azienda Ospedaliera Universitaria Integrata Verona
(Borgo Roma)
Piazzale L. A. Scuro 10, 37135 Verona
Azienda Ospedaliera Universitaria Integrata Verona
(Borgo Trento)
Piazzale A. Stefani 1, 37127 Verona
Azienda Ospedaliera San Filippo Neri
Piazza S. Maria Della Pieta’ 5, 00135 Rome
Azienda Ospedaliera Careggi
Viale Morgagni 85, 50134 Florence
Ospedale Perrino
Strada Statale 7 Mesagne, 72100 Brindisi
Ospedale Monaldi
Via Leonardo Bianchi 1, 80131 Napoli
Azienda Ospedaliera San Martino
Largo Rosanna Benzi, 1 60132 Genoa
Policlinico S. Orsola Malpighi
Via Pietro Albertoni 15, 40121 Bologna
Azienda Ospedaliera Nuovo S: Giovanni Di Dio
Firenze
Via Torre Galli 3, 50122 Florence
Ospedale Policlinico Tor Vergata
Viale Oxford 81, 00155 Rome
Ospedale S. Giovanni Battista ‘‘Le Molinette"
Corso Bramante 88/90, 10126 Turin
Azienda Di Rilievo Nazionale E Di Alta
Specializzazione Civico G. Di Cristina Fatebenefratelli
Piazzale Leotta 4, 90127 Palermo
Spain
Hospital Universitari Vall D’Hebron
Passeig De La Vall d’Hebron, 119-129 08035,
Barcelona
Hospital Universitario Puerta De Hierro
Majadahonda Manuel de Falla, 1. 2822.
Hospital Universitario La Paz
P De La Castellana, 261 28046, Madrid
Hospital Universitari de Bellvitge
Calle Feixa Llarga S/N. L’Hospitalet De Llobregat.
08907, Barcelona
Hospital A Corun˜a
Xubias De Arriba S/N 15006 A Corun˜a
Hospital General Universitario De Elche
Camino De La Almazara 11, 3202 Elche, Alicante
Hospital Universitario Ramon Y Cajal
Ctra. De Colmenar Viejo Km. 9,100, 28034, Madrid
Hospital Xeral-Cies
Rua Pizarro 22, 36204, Vigo
Hospital Clinic De Barcelona
Calle Villaroel 170, 08036, Barcelona
Hospital La Fe
Avda Campanar 21, 46009, Valencia
Hospital Txagorritxu
Calle Jose Atxotegi S/N 01006, Vitoria
Hospital Universitario Central De Asturias
Calle Celestino Villamil, S/N 33006, Oviedo
Hospital Universitario Rio Hortega
Calle Dulzaina 2, 47012, Valladolid
Hospital Universitario Virgen Del Rocio
Avda. Manuel Siurot S/N. 41013, Seville
United Kingdom
Hull Royal Inﬁrmary General Intensive Care Unit
Anlaby Road, Hull
Southampton General
Tremona Road, Southampton
Queen Alexandra
Cosham Portsmouth
Derriford Hospital
Crownhill, Plymouth, Devon
St James University Hospital
Leeds General Inﬁrmary, Great George Street, Leeds
Leeds General Inﬁrmary
Great George Street, Leeds
Musgrove Park Hospital
Taunton, Somerset
Royal Blackburn Hospital
Haslingden Road, Blackburn
Airedale
Skipton Rd, Steeton, Keighley, West Yorkshire
Warwick Hospital
Lakin Road, Warwick
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